Search results
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 1 day agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Motley Fool via Yahoo Finance· 2 days agoCan Moderna bounce back for investors who buy the dip? To find out, let's look at some reasons the ...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 4 days agoFurther, the companies are running a late-stage study in non-small cell lung cancer patients. One...
Moderna Investors Just Got Some Bullish News
The Motley Fool via AOL· 2 days agoBut in later pandemic days, investors started worrying about Moderna's dependence on its only commercialized product, and that has weighed on the stock...
Insider Selling: Moderna, Inc. (NASDAQ:MRNA) Insider Sells 1,296 Shares of Stock
ETF DAILY NEWS· 6 days agoFollowing the completion of the sale, the insider now owns 10,623 shares in the company, valued at approximately $1,725,918.81. The sale was disclosed in a filing with the Securities & Exchange ...
The U.S. Is Close To Bankrolling Moderna's Bird Flu Vaccine As Third Dairy Worker Tests Positive
Investor's Business Daily· 5 days agoModerna stock seesawed Thursday after confirming the U.S. government is nearing a deal to fund its...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 5 hours agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via Yahoo Finance· 1 day agoMonday, Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc (NYSE:MRK) announced the first presentation of...
Moderna's mRNA bird flu vaccine trial is close to getting U.S. government funding
Quartz· 5 days agoThe U.S. government is close to finalizing a deal to fund a late-stage trial of Moderna’s mRNA H5N1...
Study shows new cancer vaccine to treat melanoma has 96% survival rate
UNILAD· 6 hours agoA new vaccine treatment for skin cancer melanoma has shown extremely promising results in a new...
